Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 10:44AM ET
54.66
Dollar change
+0.64
Percentage change
1.18
%
IndexRUT P/E- EPS (ttm)-3.77 Insider Own6.01% Shs Outstand80.04M Perf Week8.07%
Market Cap4.37B Forward P/E- EPS next Y-3.89 Insider Trans-7.16% Shs Float75.22M Perf Month3.52%
Income-258.54M PEG- EPS next Q-0.91 Inst Own100.60% Short Float8.13% Perf Quarter24.71%
Sales0.00M P/S- EPS this Y-0.22% Inst Trans1.26% Short Ratio9.68 Perf Half Y17.17%
Book/sh10.47 P/B5.22 EPS next Y-5.28% ROA-42.08% Short Interest6.11M Perf Year100.00%
Cash/sh10.78 P/C5.07 EPS next 5Y- ROE-47.66% 52W Range25.35 - 55.78 Perf YTD53.63%
Dividend Est.- P/FCF- EPS past 5Y-10.59% ROI-29.49% 52W High-2.01% Beta0.62
Dividend TTM- Quick Ratio16.09 Sales past 5Y64.83% Gross Margin-105.50% 52W Low115.62% ATR (14)2.05
Dividend Ex-Date- Current Ratio16.09 EPS Y/Y TTM-10.61% Oper. Margin0.00% RSI (14)60.61 Volatility3.90% 4.00%
Employees290 Debt/Eq0.06 Sales Y/Y TTM-100.00% Profit Margin- Recom1.21 Target Price69.21
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q0.21% Payout- Rel Volume1.56 Prev Close54.02
Sales Surprise-14.62% EPS Surprise-9.44% Sales Q/Q- EarningsAug 08 AMC Avg Volume631.45K Price54.66
SMA205.57% SMA505.13% SMA20020.71% Trades Volume226,617 Change1.18%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Citigroup Buy $68
Jan-16-24Initiated Morgan Stanley Overweight $50
Dec-21-23Initiated Jefferies Hold $35
Nov-20-23Resumed JP Morgan Overweight $35
Oct-24-23Resumed Cantor Fitzgerald Overweight $52 → $50
Aug-31-23Initiated Oppenheimer Outperform $40
Apr-24-23Initiated Piper Sandler Overweight $56
Mar-30-23Initiated Robert W. Baird Outperform $48
Nov-30-21Initiated JMP Securities Mkt Outperform $43
Nov-23-21Initiated Evercore ISI Outperform $68
Sep-26-24 04:05PM
Sep-12-24 07:00PM
Sep-10-24 04:40PM
Sep-05-24 01:07AM
Sep-02-24 06:05PM
04:05PM Loading…
Aug-29-24 04:05PM
Aug-28-24 07:01PM
Aug-14-24 07:02PM
Aug-12-24 04:05PM
Aug-08-24 09:57PM
06:00PM
04:05PM
08:30AM
Aug-01-24 10:01AM
Jul-26-24 07:00PM
04:05PM Loading…
Jul-18-24 04:05PM
Jul-12-24 07:01PM
Jul-10-24 07:29PM
Jun-26-24 07:00PM
02:11PM
Jun-18-24 04:30PM
Jun-12-24 02:38AM
Jun-10-24 06:35PM
Jun-03-24 12:16PM
12:00PM
12:00PM
May-31-24 02:46AM
May-30-24 04:05PM
May-22-24 08:00AM
May-16-24 05:23PM
10:53AM Loading…
May-13-24 10:53AM
May-10-24 05:38PM
05:03PM
12:47PM
May-09-24 08:55PM
05:35PM
05:03PM
04:05PM
May-08-24 04:05PM
May-07-24 08:55AM
May-02-24 04:05PM
Apr-11-24 04:05PM
Mar-28-24 08:10AM
Mar-26-24 07:01PM
Mar-22-24 07:02PM
07:02PM
Mar-21-24 02:32AM
Mar-20-24 11:46AM
05:14AM
Mar-19-24 04:48PM
04:03PM
08:08AM
06:16AM
06:08AM
06:00AM
Mar-12-24 04:05PM
Mar-11-24 04:05PM
Mar-01-24 08:57AM
Feb-28-24 04:36PM
04:05PM
08:00AM
Feb-15-24 03:14AM
Feb-14-24 04:05PM
Feb-12-24 04:05PM
Jan-26-24 11:01PM
Jan-13-24 05:03AM
Jan-10-24 04:33PM
Jan-05-24 03:03AM
Jan-03-24 08:00AM
Dec-29-23 07:02AM
Dec-23-23 05:01AM
Dec-18-23 04:05PM
Dec-11-23 04:05PM
Dec-03-23 05:25AM
Nov-20-23 04:05PM
Nov-17-23 08:39AM
Nov-10-23 05:00PM
Nov-09-23 05:45AM
Nov-08-23 09:55AM
08:50AM
Nov-07-23 04:05PM
Nov-04-23 05:03AM
Oct-23-23 09:55AM
08:50AM
Oct-20-23 01:02AM
Oct-11-23 09:00AM
Oct-10-23 05:00PM
Oct-03-23 07:00AM
Sep-28-23 11:18AM
Sep-20-23 08:00AM
Sep-15-23 08:37AM
Sep-12-23 10:26PM
Sep-11-23 04:04PM
04:01PM
12:57PM
06:00AM
05:43AM
Sep-10-23 10:00AM
Sep-05-23 08:55PM
Aug-13-23 09:02AM
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilson MarcCFOSep 26 '24Option Exercise15.2925,000382,250136,092Sep 30 05:01 PM
Wilson MarcCFOSep 26 '24Sale51.1125,0001,277,750111,092Sep 30 05:01 PM
MARC WILSONOfficerSep 26 '24Proposed Sale51.1025,0001,277,625Sep 26 04:06 PM
Betz Stephen F.Chief Scientific OfficerSep 10 '24Sale51.501,03553,30268,576Sep 12 04:30 PM
Betz Stephen F.OfficerSep 10 '24Proposed Sale51.501,03553,301Sep 10 12:11 PM
Betz Stephen F.Chief Scientific OfficerAug 26 '24Sale53.193,000159,57069,611Aug 28 04:31 PM
Betz Stephen F.OfficerAug 26 '24Proposed Sale53.193,000159,570Aug 26 01:16 PM
Betz Stephen F.Chief Scientific OfficerAug 12 '24Sale47.683,000143,04072,611Aug 14 04:30 PM
Betz Stephen F.OfficerAug 12 '24Proposed Sale47.683,000143,050Aug 12 11:35 AM
Betz Stephen F.Chief Scientific OfficerJul 25 '24Sale53.433,000160,29075,611Jul 26 04:38 PM
Wilson MarcCFOJul 25 '24Option Exercise9.2819,056176,840130,148Jul 26 04:24 PM
Wilson MarcCFOJul 25 '24Sale53.8819,0561,026,737111,092Jul 26 04:24 PM
Knight Jeff E.Chief Operating OfficerJul 15 '24Option Exercise22.5926,073589,11678,653Jul 17 05:35 PM
Knight Jeff E.Chief Operating OfficerJul 15 '24Sale55.0027,0001,485,00051,653Jul 17 05:35 PM
Wilson MarcCFOJul 15 '24Option Exercise20.0225,000500,500136,092Jul 17 05:14 PM
Wilson MarcCFOJul 15 '24Sale55.0025,0001,375,000111,092Jul 17 05:14 PM
Betz Stephen F.Chief Scientific OfficerJul 10 '24Sale48.553,000145,65078,611Jul 12 04:30 PM
Hassard JamesChief Commercial OfficerJul 05 '24Option Exercise19.7315,000295,95044,259Jul 09 06:04 PM
Hassard JamesChief Commercial OfficerJul 05 '24Sale44.0815,000661,20029,259Jul 09 06:04 PM
Pizzuti DanaChief Med and Dev OfficerJul 03 '24Option Exercise16.8914,375242,79442,882Jul 05 04:30 PM
Pizzuti DanaChief Med and Dev OfficerJul 03 '24Sale44.8714,375645,00628,507Jul 05 04:30 PM
Wilson MarcCFOJun 28 '24Option Exercise9.2832,129298,157143,221Jul 02 04:32 PM
Wilson MarcCFOJun 28 '24Sale43.6132,1291,401,146111,092Jul 02 04:32 PM
Knight Jeff E.Chief Operating OfficerJun 26 '24Sale44.3895642,42752,580Jun 28 05:31 PM
Betz Stephen F.Chief Scientific OfficerJun 25 '24Sale45.373,000136,11080,643Jun 26 04:32 PM
Pizzuti DanaChief Med and Dev OfficerJun 24 '24Option Exercise16.899,500160,45537,286Jun 25 05:03 PM
Pizzuti DanaChief Med and Dev OfficerJun 24 '24Sale45.739,500434,43527,786Jun 25 05:03 PM
Hassard JamesChief Commercial OfficerJun 21 '24Option Exercise19.7315,000295,95044,259Jun 24 05:08 PM
Hassard JamesChief Commercial OfficerJun 21 '24Sale44.6615,000669,90029,259Jun 24 05:08 PM
Betz Stephen F.Chief Scientific OfficerJun 10 '24Sale43.863,000131,58083,643Jun 11 04:35 PM
Betz Stephen F.Chief Scientific OfficerMay 28 '24Sale47.493,000142,47086,643May 30 04:28 PM
Betz Stephen F.Chief Scientific OfficerMay 10 '24Sale49.433,000148,29089,643May 14 06:29 PM
Struthers Richard ScottPresident & CEOMay 08 '24Option Exercise9.28107,448997,117364,933May 10 04:57 PM
Struthers Richard ScottPresident & CEOMay 08 '24Sale49.40107,4485,307,931257,485May 10 04:57 PM
Pizzuti DanaChief Med and Dev OfficerApr 15 '24Option Exercise16.8914,375242,79442,161Apr 17 04:36 PM
Pizzuti DanaChief Med and Dev OfficerApr 15 '24Sale44.4714,375639,25627,786Apr 17 04:36 PM
Struthers Richard ScottPresident & CEOApr 15 '24Option Exercise1.9120,00038,200257,835Apr 17 04:30 PM
Struthers Richard ScottPresident & CEOApr 04 '24Option Exercise9.2840,951380,025278,786Apr 08 05:09 PM
Struthers Richard ScottPresident & CEOApr 04 '24Sale49.1740,9512,013,561237,835Apr 08 05:09 PM
Okey StephanieDirectorMar 28 '24Option Exercise18.2917,500320,07523,500Apr 02 04:35 PM
Okey StephanieDirectorMar 28 '24Sale46.3817,500811,6506,000Apr 02 04:35 PM
Knight Jeff E.Chief Operating OfficerMar 22 '24Option Exercise23.9830,000719,40084,939Mar 26 04:30 PM
Knight Jeff E.Chief Operating OfficerMar 22 '24Sale44.3132,3591,433,67552,580Mar 26 04:30 PM
Pizzuti DanaChief Med and Dev OfficerMar 20 '24Option Exercise16.8914,375242,79438,500Mar 22 04:52 PM
Pizzuti DanaChief Med and Dev OfficerMar 20 '24Sale44.0615,089664,76327,786Mar 22 04:52 PM
Fust Matthew KDirectorMar 20 '24Option Exercise20.9260,0001,254,97536,036Mar 22 04:31 PM
Fust Matthew KDirectorMar 20 '24Sale44.1460,0002,648,15018,536Mar 22 04:31 PM
Wilson MarcCFOMar 19 '24Sale42.916,942297,881110,630Mar 20 06:32 PM
Betz Stephen F.Chief Scientific OfficerJan 25 '24Sale37.263,000111,78073,298Jan 26 05:50 PM
Betz Stephen F.Chief Scientific OfficerJan 10 '24Sale37.653,000112,95076,298Jan 12 04:12 PM
Pizzuti DanaChief Med and Dev OfficerJan 03 '24Option Exercise16.8914,375242,79420,286Jan 04 04:45 PM
Pizzuti DanaChief Med and Dev OfficerJan 03 '24Sale35.0014,375503,1255,911Jan 04 04:45 PM
Wilson MarcCFOJan 02 '24Option Exercise9.2810,00092,800106,055Jan 04 04:43 PM
Wilson MarcCFOJan 02 '24Sale35.4710,000354,70096,055Jan 04 04:43 PM
Betz Stephen F.Chief Scientific OfficerDec 26 '23Sale35.893,000107,67079,298Dec 27 05:20 PM
Pizzuti DanaChief Med and Dev OfficerDec 21 '23Option Exercise16.899,583161,85715,494Dec 22 06:45 PM
Pizzuti DanaChief Med and Dev OfficerDec 21 '23Sale34.579,583331,2845,911Dec 22 06:45 PM
Betz Stephen F.Chief Scientific OfficerDec 11 '23Sale32.873,00098,61082,298Dec 13 04:44 PM
Betz Stephen F.Chief Scientific OfficerNov 27 '23Sale31.843,00095,52085,298Nov 29 04:31 PM
Struthers Richard ScottPresident & CEONov 09 '23Option Exercise1.9150,00095,500185,522Nov 13 04:33 PM
Struthers Richard ScottPresident & CEONov 03 '23Option Exercise9.28199,0821,847,481334,604Nov 06 06:02 PM
Struthers Richard ScottPresident & CEONov 02 '23Option Exercise9.289188,519136,440Nov 06 06:02 PM
Struthers Richard ScottPresident & CEONov 03 '23Sale30.56199,0826,083,946135,522Nov 06 06:02 PM
Struthers Richard ScottPresident & CEONov 02 '23Sale29.9591827,494135,522Nov 06 06:02 PM
Wilson MarcCFONov 01 '23Option Exercise9.2810,00092,800105,601Nov 03 07:38 PM
Wilson MarcCFONov 01 '23Sale28.7510,000287,50095,601Nov 03 07:38 PM
Krasner Alan SethChief Medical OfficerOct 17 '23Option Exercise12.017,00084,07050,210Oct 19 05:01 PM
Krasner Alan SethChief Medical OfficerOct 17 '23Sale30.007,000210,00043,210Oct 19 05:01 PM